Cases & Deals

Share

Auriga Partners and Kreaxi invest in Nosopharm

March 2017

Client(s) Auriga Partners and Kreaxi

Jones Day represented Auriga Partners and Kreaxi in connection with their investment in Nosopharm, a France-based biotechnology company specialized in the research and development of new antimicrobial molecules. Alto Invest acted as co-investor in the investment round.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.